•
Dec 31, 2020

LifeMD Q4 2020 Earnings Report

LifeMD's Q4 2020 revenue increased by 227% reaching a record of $12.9 million.

Key Takeaways

LifeMD reported a significant increase in revenue for Q4 2020, reaching a record $12.9 million, a 227% increase compared to the same period last year. This growth was primarily driven by a substantial increase in telemedicine product revenues. The company is forecasting revenue to range between $85 million and $95 million for the full year 2021.

Q4 2020 revenue increased by 227% to a record $12.9 million.

Telemedicine product revenues increased by 293%.

PDFSimpli subsidiary contributed net sales of $2.6 million, up 96%.

The company is forecasting revenue to range between $85 million and $95 million for the full year 2021.

Total Revenue
$12.9M
Previous year: $3.94M
+226.9%
EPS
-$2.49
Previous year: -$0.0665
+3643.8%
New Telemedicine Patients
200%
Previous year: 100%
+100.0%
Subscription Rate
91%
Previous year: 20%
+355.0%
Gross Profit
$8.9M
Previous year: $2.69M
+231.2%
Cash and Equivalents
$9.2M

LifeMD

LifeMD

LifeMD Revenue by Segment

Forward Guidance

For the full year 2021, the company is forecasting revenue to range between $85 million and $95 million, or grow 128% to 155%.

Positive Outlook

  • Revenue is expected to range between $85 million and $95 million for the full year 2021.
  • Revenue is expected to grow 128% to 155% for the full year 2021
  • Subscription rate for new telemedicine orders has grown.
  • Plans to launch additional telehealth products and services.
  • Expansion of digital health ecosystem.

Revenue & Expenses

Visualization of income flow from segment revenue to net income